Palifosfamide
Palifosfamide is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
560 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lymphoma | D008223 | — | C85.9 | 30 | 105 | 26 | 7 | 6 | 160 |
| Sarcoma | D012509 | — | — | 23 | 72 | 33 | 3 | 18 | 137 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 14 | 38 | 12 | 3 | 1 | 60 |
| Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 18 | 34 | 6 | 1 | 3 | 54 |
| B-cell lymphoma | D016393 | — | — | 13 | 31 | 7 | 1 | 1 | 45 |
| Germ cell and embryonal neoplasms | D009373 | — | — | 8 | 29 | 8 | 1 | 2 | 40 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 4 | 11 | 12 | 5 | 2 | 32 |
| Leukemia | D007938 | — | C95 | 4 | 15 | 10 | 3 | 2 | 32 |
| T-cell lymphoma | D016399 | — | — | 6 | 16 | 2 | 3 | — | 25 |
| T-cell lymphoma peripheral | D016411 | — | — | 6 | 12 | 2 | 3 | — | 21 |
Show 12 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | — | C80 | 26 | 19 | 8 | — | 4 | 48 |
| Osteosarcoma | D012516 | — | — | 12 | 29 | 8 | — | 7 | 48 |
| Hodgkin disease | D006689 | — | C81 | 9 | 20 | 9 | — | 1 | 32 |
| Ewing sarcoma | D012512 | EFO_0000173 | — | 5 | 12 | 6 | — | 5 | 27 |
| Rhabdomyosarcoma | D012208 | — | — | 3 | 14 | 5 | — | 2 | 22 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 8 | 14 | 5 | — | — | 21 |
| Recurrence | D012008 | — | — | 9 | 12 | 2 | — | 1 | 20 |
| Neuroblastoma | D009447 | EFO_0000621 | — | 7 | 9 | 4 | — | 2 | 20 |
| Lung neoplasms | D008175 | — | C34.90 | 3 | 7 | 7 | — | 2 | 17 |
| Central nervous system neoplasms | D016543 | — | — | 4 | 10 | 2 | — | 1 | 14 |
Show 67 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 2 | 8 | — | — | — | 9 |
| Primitive neuroectodermal tumors | D018242 | — | — | 1 | 3 | — | — | 4 | 8 |
| Urinary bladder neoplasms | D001749 | — | C67 | 1 | 6 | — | — | — | 6 |
| Transitional cell carcinoma | D002295 | — | — | 2 | 5 | — | — | — | 6 |
| Mantle-cell lymphoma | D020522 | — | C83.1 | 4 | 5 | — | — | — | 6 |
| Wilms tumor | D009396 | EFO_0000212 | — | 3 | 2 | — | — | 1 | 6 |
| Drug-related side effects and adverse reactions | D064420 | — | T88.7 | — | 3 | — | — | 2 | 5 |
| Penile neoplasms | D010412 | — | C60 | — | 5 | — | — | — | 5 |
| Desmoplastic small round cell tumor | D058405 | — | — | 1 | 3 | — | — | — | 4 |
| Mycosis fungoides | D009182 | — | C84.0 | 3 | 1 | — | — | — | 3 |
Show 79 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Rhabdoid tumor | D018335 | — | — | 2 | — | — | — | 1 | 3 |
| Hepatoblastoma | D018197 | — | C22.2 | 2 | — | — | — | 1 | 3 |
| Medulloblastoma | D008527 | — | — | 1 | — | — | — | 1 | 2 |
| Retinoblastoma | D012175 | — | — | 1 | — | — | — | 1 | 2 |
| Interdigitating dendritic cell sarcoma | D054739 | — | C96.4 | 1 | — | — | — | 1 | 2 |
| Pharmacokinetics | D010599 | — | — | 2 | — | — | — | — | 2 |
| Blastic plasmacytoid dendritic cell neoplasm | D000099067 | — | C86.4 | 1 | — | — | — | — | 1 |
| Intestinal diseases | D007410 | — | K63.9 | 1 | — | — | — | — | 1 |
| Thymoma | D013945 | — | — | 1 | — | — | — | — | 1 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | 1 | — | — | — | — | 1 |
Show 14 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pituitary diseases | D010900 | — | E23.7 | — | — | — | — | 2 | 2 |
| Retinal neoplasms | D019572 | — | C69.2 | — | — | — | — | 1 | 1 |
| Disease | D004194 | EFO_0000408 | R69 | — | — | — | — | 1 | 1 |
| Thyroid diseases | D013959 | — | E00-E07 | — | — | — | — | 1 | 1 |
| Pituitary neoplasms | D010911 | — | — | — | — | — | — | 1 | 1 |
| Sex cord-gonadal stromal tumors | D018312 | EFO_1000052 | — | — | — | — | — | 1 | 1 |
| Pinealoma | D010871 | — | — | — | — | — | — | 1 | 1 |
| Sertoli-leydig cell tumor | D018310 | — | — | — | — | — | — | 1 | 1 |
| Nodular goiter | D006044 | EFO_1001062 | — | — | — | — | — | 1 | 1 |
| Hyperplasia | D006965 | EFO_0000536 | — | — | — | — | — | 1 | 1 |
Show 21 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Palifosfamide |
| INN | palifosfamide |
| Description | Isophosphamide mustard is a phosphorodiamide. |
| Classification | Small molecule |
| Drug class | phosphoro-derivatives; isophosphoramide mustard derivatives |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | O=P(O)(NCCCl)NCCCl |
Identifiers
| PDB | — |
| CAS-ID | 31645-39-3 |
| RxCUI | — |
| ChEMBL ID | CHEMBL889 |
| ChEBI ID | 80566 |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | 6A4U6NN813 (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 9,999 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
13 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use